News Daily News Pot Talk: Review Urges Cardiologists to Discuss Marijuana Use L.A. McKeown January 21, 2020
News Daily News Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication Michael O'Riordan January 17, 2020
News Daily News Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL Michael O'Riordan January 17, 2020
News Daily News Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes Michael O'Riordan January 14, 2020
News Daily News Program to Cut Hospital Readmissions Has Not Changed Racial Disparities in Acute MI L.A. McKeown January 09, 2020
News Daily News Diastolic BP, Heart Rate Strongly Linked to Death in Chronic Aortic Regurgitation Todd Neale January 08, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2019 Shelley Wood December 31, 2019
News Daily News FDA: Class I Recall for Cook Medical’s CrossCath Support Catheters L.A. McKeown December 17, 2019
News Daily News Higher Chili Pepper Consumption Linked to Fewer CVD Deaths L.A. McKeown December 17, 2019
News Daily News FDA Approves Icosapent Ethyl for Reducing CVD Events Michael O'Riordan December 13, 2019
News Daily News Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk Michael O'Riordan December 03, 2019
News Daily News Cannabis Abuse Linked to Periprocedural MIs After Elective Surgeries Shelley Wood December 03, 2019
News Daily News Physicians as Patients: Better Health, Less CV Prevention Among Ontario Doctors Than General Public Yael L. Maxwell November 26, 2019
News Conference News AHA 2019 Inclisiran in FH: Safe, Cuts LDL in This Challenging Group Yael L. Maxwell November 19, 2019
News Conference News AHA 2019 Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR Todd Neale November 17, 2019
News Conference News AHA 2019 Inclisiran Slashes LDL in ASCVD Patients: ORION-10 Yael L. Maxwell November 16, 2019
News Conference News AHA 2019 COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine Caitlin E. Cox November 16, 2019
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019